Gilead Sciences Inc (NASDAQ:GILD)

102.93
BATS BZX Real-Time Price
As of 3:25pm ET
 +0.14 / +0.14%
Today’s Change
63.50
Today|||52-Week Range
116.83
+9.20%
Year-to-Date
The Biotechs Are Feeling Better
12:34pm / TheStreet.com
Biotech Head-to-Head: Gilead vs. Celgene
Feb 26 / MotleyFool.com
3 Drugs Stocks Moving The Industry Upward
12:14pm / TheStreet.com
UPDATE: Gilead Reports Preclinical Data
Feb 25 / Benzinga
Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analy...
12:07pm / Zacks.com
Why Pharmacyclics, Inc. Soared Higher Today
Feb 25 / MotleyFool.com
Nasdaq dogs: Cisco, Sirius and Yahoo got left behind
Mar 03 / CNNMoney.com
I turned a 'fake' $1 million into $120 million -- what I'd buy now
Feb 25 / CNNMoney.com
Nasdaq Hits 5000: 3 Choices to Ride the Upswing - Analyst Blog
Mar 03 / Zacks.com
Billions on the Line in the Next Drug Pricing War
Feb 24 / MotleyFool.com
Dynavax Technologies: A New 'Best Idea'
Mar 03 / TheStreet.com
3 Stocks Pre-Retirees Can Buy and Hold for the Next 20 Years
Feb 23 / MotleyFool.com
Gilead's (GILD) HIV Drug Positive in 2 Phase III Studies - Analyst Blog
Mar 02 / Zacks.com
3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever
Feb 22 / MotleyFool.com
11 stocks hedge funds and mutual funds love now
Mar 02 / CNNMoney.com
Did Researchers Just Discover a Cure for HIV/AIDS?
Feb 22 / MotleyFool.com
Nasdaq 5,000 Is Signaling a 'Broader' Bull Market in Stocks
Mar 02 / TheStreet.com
3 Tiny Biotech Stocks That I'm Paying Attention to in 2015
Feb 22 / MotleyFool.com
Stock Market News for March 02, 2015 - Market News
Mar 02 / Zacks.com
Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog
Feb 20 / Zacks.com
Why Don't These Winning Stocks Pay Dividends?
Mar 01 / MotleyFool.com
11.7 Billion Reasons Gilead Sciences, Inc. Should Keep Winning
Feb 19 / MotleyFool.com
Billionaire George Soros Just Dumped These 3 Dividend Stocks
Mar 01 / MotleyFool.com
Is Gilead Sciences Inc. Stock Cheap Now?
Feb 18 / MotleyFool.com
3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
Mar 01 / MotleyFool.com
Top hedge fund dumps Apple, buys Microsoft
Feb 12 / CNNMoney.com
This Breakthrough Study May Allow Researchers to Tackle the Root Cause of Heart Disea...
Feb 28 / MotleyFool.com
Healthcare: The race to cure rising drug costs
Feb 10 / FT.com
ImmunoVaccine Up 24% On Deal With Gilead Sciences
Feb 27 / Benzinga
Gilead sinks on discounting worries
Feb 04 / FT.com
3 Health Care Stocks Dragging The Sector Down
Feb 27 / TheStreet.com
Stocks: 4 things to know before the open
Feb 04 / CNNMoney.com
UPDATE: Gilead Press Release Regarding Phase 3 Harvoni Study
Feb 26 / Benzinga
Gilead to cut price of $1,000-a-day pill
Feb 03 / FT.com
Is Nasdaq's Move to 5,000 Different This Time or Are Stocks Undervalued?
Feb 26 / TheStreet.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account